Diagnostic Yield of the New Bárány Society Criteria for Pediatric Episodic Vestibular Syndrome
Metadatos
Mostrar el registro completo del ítemAutor
Rey-Berenguel, Mar; Vallecillo-Zorrilla, Javier; Burgueño-Uriarte, Edith Karelly; Olvera-Porcel, María del Carmen; Espinosa Sánchez, Juan ManuelEditorial
MDPI
Materia
Vestibular disease Vertigo Migraine disorders
Fecha
2025-08-23Referencia bibliográfica
Rey-Berenguel, M.; Vallecillo-Zorrilla, J.; BurgueñoUriarte, E.K.; Olvera-Porcel, M.d.C.; Espinosa-Sanchez, J.M. Diagnostic Yield of the New Bárány Society Criteria for Pediatric Episodic Vestibular Syndrome. J. Clin. Med. 2025, 14, 5971. https://doi.org/10.3390/jcm14175971
Resumen
Background/Objectives: Pediatric episodic vestibular syndrome (EVS) is increasingly
recognized, with recurrent vertigo of childhood (RVC) and vestibular migraine of childhood
(VMC) being the most prevalent disorders. In 2021, the Bárány Society and the International
Headache Society proposed new diagnostic criteria for RVC, VMC, and probable VMC
(pVMC), replacing the older term benign paroxysmal vertigo (BPV). This study aimed
to evaluate the clinical applicability of these new criteria. Methods: We conducted a
cross-sectional study at a pediatric neurotology clinic within a tertiary hospital, including
patients under 18 years with episodic vestibular symptoms evaluated between 2018 and
2025. All patients underwent a standardized neuro-otological assessment. Diagnoses
were assigned using both the 2018 ICHD-3 and the 2021 Bárány criteria. Patients who
did not fulfill any of the three new diagnostic categories, nor met criteria for any other
specific vestibular disorder, were grouped into an undetermined category referred to as
episodic vestibular syndrome without hearing loss (EVSw/oHL). Demographic and clinical
variables were compared across diagnostic groups using non-parametric and chi-squared
tests. Results: Among the 202 children evaluated, 109 met the inclusion criteria and were
classified as RVC (n = 55), VMC (n = 23), pVMC (n = 13), or EVSw/oHL (n = 18). All
patients previously diagnosed with BPV met the new criteria for RVC. Application of
the Bárány criteria significantly reduced the proportion of unclassified EVS cases (from
35.78% to 16.51%). Significant clinical differences were observed among the groups in
terms of episode duration, presence of vomiting, migraine and headache, and family
history of migraine. Conclusions: The new Bárány criteria provide a more inclusive and
clinically meaningful framework for classifying pediatric EVS. They improve diagnostic
clarity, reduce the proportion of unclassifiable cases, and support earlier and more tailored
management strategies.





